155 related articles for article (PubMed ID: 1310099)
21. Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.
Haupt Y; Harris AW; Adams JM
Oncogene; 1992 May; 7(5):981-6. PubMed ID: 1570158
[TBL] [Abstract][Full Text] [Related]
22. Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines.
Ma A; Fisher P; Dildrop R; Oltz E; Rathbun G; Achacoso P; Stall A; Alt FW
EMBO J; 1992 Jul; 11(7):2727-34. PubMed ID: 1628630
[TBL] [Abstract][Full Text] [Related]
23. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
[TBL] [Abstract][Full Text] [Related]
24. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
Sheppard RD; Samant SA; Rosenberg M; Silver LM; Cole MD
Oncogene; 1998 Oct; 17(16):2073-85. PubMed ID: 9798678
[TBL] [Abstract][Full Text] [Related]
25. bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.
Haupt Y; Bath ML; Harris AW; Adams JM
Oncogene; 1993 Nov; 8(11):3161-4. PubMed ID: 8414519
[TBL] [Abstract][Full Text] [Related]
26. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
[TBL] [Abstract][Full Text] [Related]
27. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
28. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM
J Exp Med; 1988 Feb; 167(2):353-71. PubMed ID: 3258007
[TBL] [Abstract][Full Text] [Related]
29. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
30. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors.
Ma A; Smith RK; Tesfaye A; Achacoso P; Dildrop R; Rosenberg N; Alt FW
Mol Cell Biol; 1991 Jan; 11(1):440-4. PubMed ID: 1986238
[TBL] [Abstract][Full Text] [Related]
32. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
33. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene.
Righi M; Sassano M; Valsasnini P; Shammah S; Ricciardi-Castagnoli P
Oncogene; 1991 Jan; 6(1):103-11. PubMed ID: 1825138
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of endogenous p53 and induction of in vivo apoptosis in B-lineage lymphomas of E(mu)-myc transgenic mice by deregulated c-myc transgene.
Prasad VS; LaFond RE; Zhou M; Jacobsen KA; Osmond DG; Sidman CL
Mol Carcinog; 1997 Feb; 18(2):66-77. PubMed ID: 9049182
[TBL] [Abstract][Full Text] [Related]
35. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
36. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
Kovalchuk AL; Kim JS; Janz S
Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
[TBL] [Abstract][Full Text] [Related]
37. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
38. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
39. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
[TBL] [Abstract][Full Text] [Related]
40. Multiple mechanisms of tumorigenesis in E mu-myc transgenic mice.
Sidman CL; Denial TM; Marshall JD; Roths JB
Cancer Res; 1993 Apr; 53(7):1665-9. PubMed ID: 8453639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
